Abstract 879: A Functional Promoter Polymorphism (−1362g>t) of IL-6 Gene is Associated with the Risk of Squamous Cell Carcinoma of Head and Neck

Yu‐Jing Huang,Jiangong Niu,Lie Wang,Zhensheng Liu,Erich M. Sturgis,Qingyi Wei
DOI: https://doi.org/10.1158/1538-7445.am2011-879
IF: 11.2
2011-01-01
Cancer Research
Abstract:Interleukin-6, an immunoregulatory cytokine, plays a crucial role in the pathogenesis of a wide variety of human cancers, and the IL-6 levels have been shown to be associated with tumor progression in human squamous cell carcinoma of the head and neck (SCCHN). Because the presence of polymorphisms in the non-coding gene regulatory region may affect transcriptional regulation of IL-6, we hypothesized that such genetic variants of IL-6 might contribute to susceptibility to SCCHN. To assess the association between IL-6 polymorphisms and SCCHN risk, two independent IL-6 promoter SNPs, -1362 G>T (rs2069827) and -597 G>A (rs1800797), the latter being in nearly complete linkage disequilibrium with -173 C>G (rs1800795), were genotyped in 1,092 non-Hispanic White SCCHN patients and 1,126 age-and sex-matched cancer-free controls. After adjustment for age, sex, and smoking and drinking status, a significantly higher risk was observed for the -1362GT+TT genotypes (adjusted OR = 1.28, 95% CI = 1.01-1.62), compared with those carrying the -1362GG homozygotes, but not for the -597G>A SNP. Additional functional experiment demonstrated that the IL-6 SNP -1362 G-to-T allelic change was associated with an increased promoter activity in human head and neck cell lines, supporting the hypothesis that genetic polymorphism influencing IL-6 transcription may play a role in human SCCHN carcinogenesis. We conclude that the IL-6 promoter -1362 G>T (rs2069827) polymorphism is functional, modulating susceptibility to SCCHN among non-Hispanic Whites. Larger studies are needed to validate our findings. (Supported by NIH grants R01CA131274, R01ES011740 and P30 CA016672) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 879. doi:10.1158/1538-7445.AM2011-879
What problem does this paper attempt to address?